Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ HPGDS Monoclonal Antibody (735301)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA524347
Description
Reconstitute in sterile PBS to a final concentration of 0.5 mg/mL.
PGDS is a sigma class glutathione-S-transferase family member. The enzyme catalyzes the conversion of PGH2 to PGD2 and plays a role in the production of prostanoids in the immune system and mast cells. The presence of this enzyme can be used to identify the differentiation stage of human megakaryocytes. Prostaglandin-D synthase is a sigma class glutathione-S-transferase family member. The enzyme catalyzes the conversion of PGH2 to PGD2 and plays a role in the production of prostanoids in the immune system and mast cells. The presence of this enzyme can be used to identify the differentiation stage of human megakaryocytes.
Specifications
HPGDS | |
Monoclonal | |
0.5 mg/mL | |
PBS with 5% trehalose and No Preservative | |
O60760 | |
Hpgds | |
E. coli-derived recombinant human Hematopoietic Prostaglandin D Synthase/HPGDS Pro2-Leu199. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG1 |
Western Blot, Immunocytochemistry | |
735301 | |
Unconjugated | |
Hpgds | |
EC 2.5.1.18; EC 5.3.99.2; glutathione S-transferase; glutathione S-transferase sigma; glutathione-dependent PGD synthase; glutathione-dependent PGD synthetase; glutathione-requiring prostaglandin D synthase; GST class-sigma; GSTS; GSTS1; GSTS1-1; hematopoietic prostaglandin D synthase; hematopoietic prostaglandin D2 synthase; Hpgds; H-PGDS; PGD2; PGDS; prostaglandin D2 synthase 2, hematopoietic; prostaglandin D2 synthase, hematopoietic; prostaglandin-H2 D-isomerase; Ptgds2 | |
Mouse | |
Protein A/G | |
RUO | |
27306 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Lyophilized |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction